Stocks capped a choppy day of trading on Wall Street with more losses Thursday after an early big tech rally faded and a ...

Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.

If action is not taken within 60 days, the White House said it would “deploy every tool in our arsenal” to improve drug pricing practices for American patients.

The FDA issued a complete response letter for Regeneron's lymphoma drug odronextamab. Elsewhere, Bristol Myers raised its ...